Evidence map›Paper›PMID 41221174›Full record

ReviewClinical and experimental vaccine research2025

A narrative review of monkey B virus (

Hyoungjoon Moon, Kwang-Soo Lyoo

Abstract readReview
In one paragraph

Review in Clinical and experimental vaccine research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hyoungjoon MoonDepartment of Animal Health and Welfare, Semyung University, Jecheon, Korea.ORCID https://orcid.org/0000-0001-6211-8758
Kwang-Soo LyooDepartment of Veterinary Nursing, College of Health Sciences, Wonkwang University, Iksan, Korea.ORCID https://orcid.org/0000-0002-3380-6890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes B virus (BV) is enzootic to macaques and represents a significant zoonotic threat to humans. In macaques, the viral infection is typically latent and asymptomatic, however, BV can become a deadly neurotropic infection in humans, commonly leading to encephalomyelitis. Although seroprevalence among macaques is widespread, particularly in wild-caught or laboratory-maintained populations, zoonotic transmission has remained rare since the first documented case. The limited host range of BV contrasts with its ability to cross species barriers under specific conditions. Diagnostic challenges and delayed symptom onset can interrupt early detection and antiviral treatment. Thus, BV is a paramount concern in the context of primate research and captive animal care. Consequently, this threat will require international collaboration, comprehensive surveillance, and continued researches to prevent zoonotic transmission and maintain safe primate research environments.

Indexed as

Herpes B virusInfectionsTreatmentZoonoses

Identifiers

PMID41221174
PMCPMC12599448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.